Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -2.95%3.81B | 4.71%1.09B | -4.60%892.85M | -5.87%1.06B | -6.71%773.1M | 4.36%3.93B | 11.22%1.04B | -0.61%935.87M | 2.59%1.13B | 4.65%828.68M |
Net income from continuing operations | 4.28%2.73B | -10.21%771.76M | -19.70%546.67M | 2.14%569.44M | 61.99%841.16M | 6.71%2.62B | 11.23%859.5M | 9.47%680.76M | -2.10%557.51M | 6.34%519.26M |
Operating gains losses | 10.73%-658.49M | 47.09%-177.35M | 76.94%-58.5M | 66.73%-42.21M | -1,637.11%-380.43M | 4.09%-737.68M | -0.12%-335.22M | -55.54%-253.67M | 33.24%-126.89M | 73.02%-21.9M |
Depreciation and amortization | 1.97%1.36B | 6.44%360.6M | 2.56%341.91M | -1.91%332.6M | 0.74%324.76M | 3.21%1.33B | 0.72%338.78M | 5.39%333.36M | 7.52%339.06M | -0.53%322.39M |
Other non cash items | 492.94%76.62M | 1,476.81%77.42M | -112.76%-548K | -6.41%6.87M | -202.97%-7.12M | -34.03%12.92M | -470.86%-5.62M | 139.38%4.3M | -69.06%7.34M | -10.96%6.91M |
Change In working capital | -128.08%-72.48M | -99.78%135K | -214.23%-77.25M | -59.90%90.44M | 11.10%-85.8M | 73.38%258.13M | 4.54%61.51M | -7.49%67.62M | 93.46%225.52M | 3.12%-96.52M |
-Change in receivables | 406.40%36.16M | 76.11%-19.05M | 416.61%28.59M | -110.38%-3.8M | 18.05%30.43M | -118.63%-11.8M | -450.23%-79.74M | -64.75%5.53M | 231.68%36.63M | -71.35%25.77M |
-Change in payables and accrued expense | -48.17%127.24M | 46.31%156.31M | -121.75%-14.89M | -49.78%98.67M | 10.64%-112.84M | 29.15%245.51M | 6.24%106.83M | 52.19%68.49M | 1.84%196.46M | 14.89%-126.27M |
-Change in other working capital | -1,065.83%-235.88M | -498.43%-137.12M | -1,321.22%-90.94M | 41.55%-4.43M | -185.20%-3.39M | 123.36%24.42M | 226.40%34.42M | -151.61%-6.4M | 84.39%-7.57M | 109.66%3.98M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -2.95%3.81B | 4.71%1.09B | -4.60%892.85M | -5.87%1.06B | -6.71%773.1M | 4.36%3.93B | 11.22%1.04B | -0.61%935.87M | 2.59%1.13B | 4.65%828.68M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 203.31%1.41B | 101.01%8.82M | 551.63%811.34M | 31.34%-105.21M | 534.06%693.37M | -117.56%-1.36B | -231.68%-870.58M | -30.69%-179.64M | -20.90%-153.22M | -59.90%-159.74M |
Capital expenditure reported | 4.75%-755.58M | -22.20%-217.87M | 18.15%-186.37M | 14.85%-188.37M | 1.86%-162.97M | -22.04%-793.28M | 3.44%-178.29M | -45.92%-227.7M | -43.01%-221.23M | -7.39%-166.07M |
Net business purchase and sale | -12.66%-168.76M | -71.72%-133.8M | 99.66%-96K | -40.76%-6.94M | 27.24%-27.92M | 65.89%-149.79M | 55.13%-77.92M | -79.46%-28.57M | 96.06%-4.93M | 69.16%-38.38M |
Net investment purchase and sale | 366.95%1.94B | 127.67%196.78M | 5,153.53%893.01M | 274.91%1M | 86,970.96%851.55M | -1,716.58%-727.61M | -28,496.18%-711.19M | -8.64%-17.67M | 100.65%267K | -95.01%978K |
Net other investing changes | 271.54%31.08M | 906.78%80.99M | 136.81%921K | 697.04%51.09M | -2,741.29%-101.92M | -8.80%8.37M | 178.63%8.04M | -336.65%-2.5M | -89.37%6.41M | 93.29%-3.59M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 203.31%1.41B | 101.01%8.82M | 551.63%811.34M | 31.34%-105.21M | 534.06%693.37M | -117.56%-1.36B | -231.68%-870.58M | -30.69%-179.64M | -20.90%-153.22M | -59.90%-159.74M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -147.08%-4.99B | -897.38%-1.86B | 6.81%-768.52M | 24.70%-974.62M | -924.34%-1.38B | 33.81%-2.02B | 135.99%233.78M | -10.85%-824.66M | -36.54%-1.29B | 80.99%-135.15M |
Net issuance payments of debt | -292.91%-1.87B | -206.97%-1.07B | -24.35%12.29M | 63.18%-216.62M | -210.35%-602.05M | 456.50%971.32M | 2,534.04%997.85M | 130.42%16.25M | -250.61%-588.35M | 712.26%545.56M |
Net common stock issuance | 66.81%-53.18M | 95.99%-1.51M | 99.92%-82K | 42.88%-6.35M | -712.87%-45.24M | 15.38%-160.24M | -21,325.00%-37.71M | -191.16%-105.85M | 92.53%-11.12M | -39.61%-5.57M |
Net preferred stock issuance | -200.00%-7.5M | --0 | ---- | ---- | ---- | ---2.5M | ---2.5M | ---- | ---- | ---- |
Cash dividends paid | -8.91%-3.05B | -11.01%-792.22M | -8.05%-770.3M | -8.23%-751.21M | -8.31%-732.23M | -7.88%-2.8B | 22.04%-713.66M | -71.57%-712.89M | -8.44%-694.06M | -8.78%-676.08M |
Net other financing activities | 65.03%-11.24M | 70.26%-3.04M | 86.78%-2.93M | 37.64%-439K | -617.88%-4.84M | -1,756.86%-32.14M | -104.47%-10.21M | 90.71%-22.17M | -108.03%-704K | -74.26%934K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -147.08%-4.99B | -897.38%-1.86B | 6.81%-768.52M | 24.70%-974.62M | -924.34%-1.38B | 33.81%-2.02B | 135.99%233.78M | -10.85%-824.66M | -36.54%-1.29B | 80.99%-135.15M |
Net cash flow | ||||||||||
Beginning cash position | 88.05%1.17B | 182.19%2.17B | 47.40%1.23B | 8.28%1.25B | 88.05%1.17B | 16.42%621.63M | 27.85%769.03M | 54.73%837.47M | 124.38%1.16B | 16.42%621.63M |
Current changes in cash | -57.73%231.35M | -292.46%-769.76M | 1,467.26%935.67M | 94.76%-16.67M | -84.62%82.11M | 524.19%547.36M | 1,889.06%399.96M | -213.53%-68.43M | -1,308.46%-317.96M | 2,908.41%533.8M |
End cash Position | 19.79%1.4B | 19.79%1.4B | 182.19%2.17B | 47.40%1.23B | 8.28%1.25B | 88.05%1.17B | 88.05%1.17B | 27.85%769.03M | 54.73%837.47M | 124.38%1.16B |
Free cash flow | -2.50%3.06B | 1.07%867.68M | -0.24%706.48M | -3.69%874.78M | -7.92%610.13M | 0.67%3.14B | 14.84%858.47M | -9.86%708.17M | -4.01%908.26M | 3.98%662.61M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |